改革开放40年中国药品标准工作回顾与展望  

Retrospect and prospect of drug standard management over the four decades of reform and opening-up in China

作　　者：麻广霖[1] 张伟[1] MA Guanglin;ZHANG Wei(Chinese Pharmacopoeia Commission,Beijing 100061,China)

机构地区：[1]国家药典委员会,北京100061

出　　处：《中国药品标准》2018年第6期421-429,共9页Drug Standards of China

摘　　要：药品标准是药品质量和安全的最基本要求。改革开放以来,在党和政府的正确领导下,我国药品标准工作经历了一系列改革发展历程,取得了许多令人瞩目的成就,为药品监督管理工作提供了有力的技术支撑。在改革开放40周年之际,本文回顾了改革开放以来我国药品标准工作的发展历程,总结了40年来取得的一系列理论和实践成果,并结合当前我国药品标准工作中存在的问题提出发展思路和对策建议,为今后进一步做好药品标准工作提供借鉴和参考。Drug standard are the most basic requirement on drug quality and safety.Since of reform and openingup,drug standard management has experienced a series of reform and development under the correct leadership of the communist party of China and central government,and the remarkable achievements in drug standard are made. That provides the strong technical support for drug administration.In commemoration of the 40^th anniversary of reform and opening-up,the development of drug standard management in China are retrospected,the series of theoretical and practical achievements in drug standard management are summarized,and the development ideas and countermeasures are proposed based on the problems in drug standard management.That provides the reference for improvement of the development of drug standard.

关 键 词：改革开放 药品标准 回顾 展望 

分 类 号：R921.2[医药卫生—药学]